ANEB
Anebulo Pharmaceuticals Inc

190
Mkt Cap
$19.78M
Volume
39,066.00
52W High
$3.42
52W Low
$0.4351
PE Ratio
-2.05
ANEB Fundamentals
Price
$0.476
Prev Close
$0.4815
Open
$0.4624
50D MA
$1.46
Beta
-0.01
Avg. Volume
55,910.05
EPS (Annual)
-$0.2509
P/B
2.03
Rev/Employee
$0.00
$37.07
Loading...
Loading...
Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, Selonabant, is a small molecule antagonist of cannabinoid binding receptor type-1. The company was founded by Joseph F. Lawler on April 23, 2020 and is headquartered in Lakeway, TX.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
3

Frequently Asked Questions

What is Market Cap of Anebulo Pharmaceuticals Inc?
What is the 52-week high for Anebulo Pharmaceuticals Inc?
What is the 52-week low for Anebulo Pharmaceuticals Inc?
What is Anebulo Pharmaceuticals Inc stock price today?
What was Anebulo Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Anebulo Pharmaceuticals Inc?
What is the Price-to-Book ratio of Anebulo Pharmaceuticals Inc?
What is the 50-day moving average of Anebulo Pharmaceuticals Inc?
How many employees does Anebulo Pharmaceuticals Inc have?

Latest ANEB News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.